Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ITOS

ITeos Therapeutics Inc

May 13 • 04:00PM ET

17.02

Dollar change -0.42
Percentage change -2.41	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IBB SCHA DFAT DFAC DFAS PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.78	Insider Own	20.37%	Shs Outstand	35.84M	Perf Week	37.15%
Market Cap	612.21M	Forward P/E	-	EPS next Y	-5.59	Insider Trans	0.00%	Shs Float	28.64M	Perf Month	45.22%
Income	-135.31M	PEG	-	EPS next Q	-0.99	Inst Own	80.01%	Short Float	7.23%	Perf Quarter	56.87%
Sales	0.00M	P/S	-	EPS this Y	-40.83%	Inst Trans	-2.43%	Short Ratio	5.63	Perf Half Y	81.06%
Book/sh	15.10	P/B	1.13	EPS next Y	-25.92%	ROA	-19.93%	Short Interest	2.07M	Perf Year	20.97%
Cash/sh	12.49	P/C	1.36	EPS next 5Y	-	ROE	-22.67%	52W Range	8.20 - 18.75	Perf YTD	55.43%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-40.62%	ROI	-24.79%	52W High	-9.23%	Beta	1.40
Dividend TTM	-	Quick Ratio	13.51	Sales past 5Y	-23.53%	Gross Margin	93.02%	52W Low	107.56%	ATR (14)	1.00
Dividend Ex-Date	-	Current Ratio	13.51	EPS Y/Y TTM	-1262.29%	Oper. Margin	0.00%	RSI (14)	78.24	Volatility	6.40% 5.29%
Employees	157	Debt/Eq	0.01	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	35.40
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-144.88%	Payout	-	Rel Volume	4.08	Prev Close	17.44
Sales Surprise	-	EPS Surprise	-8.91%	Sales Q/Q	-100.00%	Earnings	May 10 BMO	Avg Volume	368.13K	Price	17.02
SMA20	47.24%	SMA50	44.95%	SMA200	53.65%	Trades		Volume	1,501,553	Change	-2.41%

Date	Action	Analyst	Rating Change	Price Target Change
May-05-21	Initiated	H.C. Wainwright	Buy	$37
Oct-08-20	Initiated	Robert W. Baird	Outperform	$45
Aug-18-20	Initiated	Wedbush	Outperform	$45
Aug-18-20	Initiated	SVB Leerink	Outperform	$45
Aug-18-20	Initiated	Piper Sandler	Overweight	$50
Aug-18-20	Initiated	JP Morgan	Overweight	$40

Today 08:28AM	HC Wainwright Adjusts Price Target on iTeos Therapeutics to $46 From $44, Maintains Buy Rating (MT Newswires)
May-10-24 01:53PM	ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q1 2024 (InvestorPlace) +43.07%
12:21PM	Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating (MT Newswires)
09:40AM	iTeos Therapeutics Q1 Net Loss Widens; Initiates $120 Million Registered Direct Offering -- Shares Jump (MT Newswires)
08:26AM	iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
08:24AM	Loading…
08:24AM	iTeos Therapeutics Announces $120 Million Registered Direct Offering (GlobeNewswire)
08:09AM	iTeos shares jump on TIGIT update; Acelyrin swaps CEOs (BioPharma Dive)
Apr-07-24 04:30PM	iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024 (GlobeNewswire)
Mar-06-24 02:51PM	ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q4 2023 (InvestorPlace) +7.80%
07:01AM	iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors (GlobeNewswire)
07:00AM	iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-05-24 04:30PM	iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024 (GlobeNewswire)
Mar-01-24 07:00AM	iTeos to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.23%
Feb-26-24 06:11AM	Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump Turn into More Strength? (Zacks)
Jan-08-24 07:00AM	iTeos Announces 2024 Strategic Priorities and Anticipated Milestones (GlobeNewswire)
07:00AM	Loading…
Jan-03-24 07:00AM	iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-13-23 09:55AM	Wall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 243.43%: Here's is How to Trade (Zacks)
Nov-27-23 09:55AM	Does iTeos Therapeutics, Inc. (ITOS) Have the Potential to Rally 283.59% as Wall Street Analysts Expect? (Zacks) -5.44%
Nov-21-23 07:00AM	iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-13-23 09:55AM	Here's Why iTeos Therapeutics, Inc. (ITOS) Could be Great Choice for a Bottom Fisher (Zacks)
Nov-10-23 09:55AM	Wall Street Analysts Predict a 304.26% Upside in iTeos Therapeutics, Inc. (ITOS): Here's What You Should Know (Zacks)
Nov-07-23 07:00AM	iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Oct-31-23 03:01AM	Viridian Therapeutics, Inc. (VRDN) Stock Jumps 5.2%: Will It Continue to Soar? (Zacks) +7.48%
Oct-16-23 01:46PM	Hedge Fund and Insider Trading News: Ken Griffin, EcoR1 Capital, Glen Point Capital, JAT Capital, Eisler Capital, Elliott Management, iTeos Therapeutics Inc (ITOS), Funko, Inc. (FNKO), and More (Insider Monkey)
04:38AM	iTeos Therapeutics, Inc. (ITOS) Stock Jumps 5.4%: Will It Continue to Soar? (Zacks)
Oct-11-23 05:55PM	NCR Atleos Set to Join S&P SmallCap 600 (PR Newswire) -6.72%
Sep-06-23 07:00AM	iTeos to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-26-23 11:02AM	BOXER CAPITAL, LLC Reduces Stake in ITeos Therapeutics Inc (GuruFocus.com)
Aug-24-23 11:30AM	Biotech Stocks Rally After Roche's (RHHBY) Accidental Data Leak (Zacks)
Aug-23-23 04:10PM	Why Roche's Accidental Cancer Update Boosted Several Rivals By As Much As 22% (Investor's Business Daily) +14.89%
02:00PM	Loading…
02:00PM	Watertown biotech shares spike after accidental data publication at Roche (American City Business Journals)
09:24AM	How Roche's Accidental Cancer Update Lifted Iteos And Arcus More Than 30% (Investor's Business Daily)
Aug-08-23 07:00AM	iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Jun-21-23 08:00PM	ITOS: Lowering target price to $11.00 (Argus Research)
May-13-23 08:03AM	Broker Revenue Forecasts For iTeos Therapeutics, Inc. (NASDAQ:ITOS) Are Surging Higher (Simply Wall St.)
May-11-23 06:11AM	iTeos Therapeutics First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
May-10-23 08:35AM	ITeos Therapeutics, Inc. (ITOS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:01AM	iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
May-05-23 08:51AM	iTeos Therapeutics (NASDAQ:ITOS) shareholders have endured a 46% loss from investing in the stock a year ago (Simply Wall St.)
Apr-26-23 08:00PM	ITOS: What does Argus have to say about ITOS? (Argus Research)
Mar-23-23 01:56PM	Down More Than 50%: 2 Strong Buy Stocks That Are Too Cheap to Ignore (TipRanks)
Mar-21-23 06:07AM	Take Care Before Jumping Onto iTeos Therapeutics, Inc. (NASDAQ:ITOS) Even Though It's 25% Cheaper (Simply Wall St.)
Mar-17-23 06:18AM	Time To Worry? Analysts Are Downgrading Their iTeos Therapeutics, Inc. (NASDAQ:ITOS) Outlook (Simply Wall St.)
Mar-15-23 08:35AM	ITeos Therapeutics, Inc. (ITOS) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:00AM	iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-28-23 07:00AM	iTeos to Present at Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-07-23 01:51PM	The 7 Best Biotech Stocks to Buy for February 2023 (InvestorPlace)
07:00AM	iTeos to Present at SVB Securities Global Biopharma Conference (GlobeNewswire)
Feb-02-23 02:19PM	The 7 Most Undervalued Biotech Stocks to Buy in February 2023 (InvestorPlace)
Jan-09-23 07:00AM	iTeos Provides Business Updates and Clinical Development Plans for 2023 (GlobeNewswire)
Jan-03-23 07:00AM	iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.07%
Dec-07-22 08:07AM	Could The Market Be Wrong About iTeos Therapeutics, Inc. (NASDAQ:ITOS) Given Its Attractive Financial Prospects? (Simply Wall St.)
Nov-22-22 07:00AM	iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire) -5.98%
Nov-10-22 07:55PM	ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates (Zacks) +11.14%
04:01PM	iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-04-22 05:46PM	Top Biotech Stocks for Q4 2022 (Investopedia)
Nov-02-22 10:00AM	ITeos Therapeutics, Inc. (ITOS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-18-22 08:36AM	Shareholders in iTeos Therapeutics (NASDAQ:ITOS) are in the red if they invested a year ago (Simply Wall St.)
Aug-12-22 06:16AM	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.) +7.00%
Aug-10-22 05:25PM	ITeos Therapeutics, Inc. (ITOS) Q2 Earnings and Revenues Lag Estimates (Zacks)
04:01PM	iTeos Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-02-22 07:00AM	iTeos to Present at the 2022 Wedbush PacGrow Healthcare Conference (GlobeNewswire)
Jun-30-22 08:41AM	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? (Simply Wall St.)
May-16-22 06:27AM	Forecast: Analysts Think iTeos Therapeutics, Inc.'s (NASDAQ:ITOS) Business Prospects Have Improved Drastically (Simply Wall St.)
May-12-22 05:45PM	ITeos Therapeutics, Inc. (ITOS) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
04:01PM	iTeos Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-11-22 04:09PM	Biotech Stocks Hammered On Roche's Unexpected Failure In Lung Cancer (Investor's Business Daily) -29.77%
07:03AM	Recent 8.9% pullback isn't enough to hurt long-term iTeos Therapeutics (NASDAQ:ITOS) shareholders, they're still up 13% over 1 year (Simply Wall St.)
Apr-08-22 01:00PM	iTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022 (GlobeNewswire)
Mar-26-22 02:51PM	Analysts Just Slashed Their iTeos Therapeutics, Inc. (NASDAQ:ITOS) EPS Numbers (Simply Wall St.)
Mar-23-22 05:55PM	ITeos Therapeutics, Inc. (ITOS) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:01PM	iTeos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire)
Mar-01-22 07:00AM	iTeos to Present at the Cowen 42nd Annual Health Care Conference (GlobeNewswire)
Feb-24-22 07:55AM	5 Drug/Biotech Stocks Set to Outpace Q4 Earnings Estimates (Zacks) +5.79%
Feb-10-22 07:00AM	iTeos to Participate in Upcoming Investor Conferences in February (GlobeNewswire)
Feb-01-22 09:38AM	Jackson Creek Investment Advisors LLC Buys ITeos Therapeutics Inc, Extreme Networks Inc, SMART ... (GuruFocus.com)
Jan-19-22 09:38AM	Asymmetry Capital Management, L.P. Buys Biomarin Pharmaceutical Inc, UnitedHealth Group Inc, ... (GuruFocus.com)
Jan-10-22 07:00AM	iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer (GlobeNewswire)
Jan-03-22 04:46PM	Why iTeos Therapeutics Topped the Market Today (Motley Fool)
04:01PM	iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-31-21 05:44PM	iTeos Therapeutics Set to Join S&P SmallCap 600 (PR Newswire)
Dec-29-21 12:19PM	ITeos Therapeutics Inc Insiders are Selling. Investors Should Take Notice (GuruFocus.com)
Dec-23-21 12:38PM	Rtw Investments, Lp Buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, ... (GuruFocus.com)
09:15AM	Iteos Therapeutics Inc (ITOS) CEO Michel Detheux Sold $2 million of Shares (GuruFocus.com)
Dec-17-21 12:38AM	Rubric Capital Management LP Buys Ferroglobe PLC, AdaptHealth Corp, CF Industries Holdings Inc, ... (GuruFocus.com) +9.23%
Dec-15-21 09:38PM	Rubric Capital Management LP Buys Ferroglobe PLC, AdaptHealth Corp, CF Industries Holdings Inc, ... (GuruFocus.com)
Dec-10-21 09:38PM	Rubric Capital Management LP Buys Ferroglobe PLC, AdaptHealth Corp, CF Industries Holdings Inc, ... (GuruFocus.com)
Dec-09-21 04:01PM	iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021 (GlobeNewswire)
Nov-22-21 10:38AM	Notable Iteos Therapeutics Insider Trades $1.1M In Company Stock (Benzinga)
Nov-16-21 12:20PM	Why iTeos Therapeutics, Inc. (ITOS) Might be Well Poised for a Surge (Zacks) +5.79%
11:07AM	Wall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 53%: Here's is How to Trade (Zacks)
Nov-10-21 05:45PM	ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates (Zacks)
04:01PM	iTeos Reports Third Quarter 2021 Financial Results and Provides Corporate Updates (GlobeNewswire)
Nov-04-21 11:24AM	Chief Executive Officer Of Iteos Therapeutics Sold $590K In Stock (Benzinga)
Nov-03-21 07:00AM	iTeos to Report Third Quarter 2021 Financial Results on November 10, 2021 (GlobeNewswire)
Oct-18-21 10:26AM	We're Not Very Worried About iTeos Therapeutics' (NASDAQ:ITOS) Cash Burn Rate (Simply Wall St.)
Sep-02-21 10:11AM	iTeos Therapeutics, Inc. (NASDAQ:ITOS) Is About To Turn The Corner (Simply Wall St.)
Sep-01-21 07:00AM	iTeos Therapeutics to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-12-21 07:00AM	iTeos Reports Second Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)
Aug-05-21 07:00AM	iTeos to Report Second Quarter 2021 Financial Results and Provide Corporate Update on August 12, 2021 (GlobeNewswire)

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gall Matthew	Chief Financial Officer	Oct 12 '23	Buy	8.37	5,000	41,850	19,429	Oct 12 05:09 PM
Boxer Capital, LLC		Aug 23 '23	Sale	16.26	350,000	5,692,673	1,804,058	Aug 25 09:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ITOS

ITeos Therapeutics Inc

Upgrade your FINVIZ experience